Authors
Huaguo Zhao, Dan Wu, Rong Ren, Licheng Ni
Published in
Minerva urology and nephrology. Nov 13, 2026. Epub Nov 13, 2026.
Abstract
Bone metastasis is a leading cause of mortality in prostate cancer (PCa) patients with limited treatment options. Myeloid-tumor cell interactions in the tumor microenvironment (TME) critically drive metastasis, but the mechanisms involved are poorly understood. Elucidating the myeloid-tumor cell crosstalk is crucial for developing novel anti-metastatic therapies.
Myeloid and tumor cell subsets were identified through single-cell RNA sequencing and copy number variation (CNV) analysis. Key signaling axes between these subsets were identified through cell-cell communication analysis. Molecular biological experiments, including qRT-PCR, Western blot, and flow cytometry, were conducted to investigate the effects of RIPK2+ macrophages on malignant tumor cell phenotypes.
RIPK2+ macrophages and disseminated tumor cells (DTCs) were enriched in tumor samples. DTCs exhibited high CNV scores and metastatic potential. RIPK2+ macrophages displayed unique antigen-presenting and immunoregulatory characteristics and engaged in high-intensity interactions with DTCs via the THBS1-CD47 signaling axis. In vitro, RIPK2 upregulated THBS1 and CD47, promoted their protein interaction, and enhanced PCa cell proliferation, migration, and invasion while repressing apoptosis.
Revealed by single-cell sequencing and molecular biological experiments, RIPK2+ macrophages promote PCa bone metastasis through the THBS1-CD47 axis. The findings expand the understanding of myeloid-tumor cell interaction networks in the TME and provide a theoretical basis for developing TME-targeted therapeutic strategies.
PMID:
43021712
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0